Please Wait
Applying Filters...
menu
    • menu
    CDMO Activity Tracker: Veranova, Carbogen lead ADC investments; Axplora, Polfa Tarchomin, Famar expand European footprint

    Data Compilation
    #PharmaFlow

    Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

    Stock Recap
    #PipelineProspector

    Menu

    Cisatracurium Besylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 33,268Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/07/2025 Seqens
    France
    		 WAVELENGTH ENTERPRISES LTD. Petah Tikva IL CEP 2016-200 - Rev 01 Cisatracurium besilate 2024-10-23 Valid Chemical 2763
    29/07/2025 Seqens
    France
    		 WAVELENGTH ENTERPRISES LTD. Petah Tikva IL CEP 2023-465 - Rev 01 Cisatracurium besilate, Process B 2024-10-24 Valid Chemical 2763